CT SB00320

Prohibits health carriers, hospital service corporations, and other health insurers from requiring step therapy for any prescribed drug lasting longer than 60 days, effective January 1, 2021.

Prohibits step therapy requirements for prescribed drugs treating disabling, chronic, or life-threatening diseases or conditions in patients diagnosed with such diseases, provided the drug complies with FDA-approved indications.

Allows a treating health care provider to deem a step therapy drug regimen clinically ineffective after the 60-day period expires, requiring insurers to authorize coverage of the provider's prescribed drug.

Applies restrictions to both individual health insurance policies (section 38a-510) and group health insurance policies (section 38a-544).

Defines "step therapy" as a protocol or program establishing the specific sequence in which prescription drugs for a medical condition are prescribed.